Clin2
NCT07637006Possibly a fitNot yet recruiting

Herbal capsule for fatty liver with metabolic issues

Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)

Part of Digestive system clinical trials.

This trial tests a traditional Chinese herbal capsule called Linzhi Jianghuang Fufang Huoxue Anshen. It aims to see if it can reduce fat in the liver and improve health in people with non-alcoholic fatty liver disease who also have conditions like high blood sugar, blood pressure, or cholesterol.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
180 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a fatty liver confirmed by an MRI scan (more than 10% fat).
  • Your liver is not stiff (less than 7.3 kPa).
  • You have at least one of: high blood sugar, high blood pressure, or high triglycerides.
  • You are willing to follow the study procedures and take the herbal capsule.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06848907Not yet recruiting· Phase 2
A herbal capsule for fatty liver disease

This study tests a Chinese herbal capsule called Ganzhixiao for people with fatty liver disease (also called MAFLD). It aims to see if the capsule can help improve liver health and reduce fat build-up, and you'll have regular check-ups including MRI scans.

NCT07320456Not yet recruiting· Phase 2
Herbal medicine for fatty liver disease

This trial tests a traditional Chinese herbal mixture called 'Longqi Jiangzhi Decoction' for people with non-alcoholic fatty liver disease. It aims to see if the herbs can improve liver health and reduce fat in the liver, possibly offering a gentler treatment option.

NCT07663643Not yet recruiting· Phase 4
Fuzheng Huayu tablets for fatty liver cirrhosis

This study tests whether a traditional Chinese medicine, Fuzheng Huayu tablets, can help people with cirrhosis caused by fatty liver disease. It aims to see if the treatment is safe and effective in stopping or slowing the disease's progression.

NCT07878091Not yet recruiting· Phase 2
Kylo-0603 for fatty liver disease

This trial tests an experimental pill called Kylo-0603 for fatty liver disease (MASLD). The pill may help reduce fat build-up in the liver and improve liver health. It is for people who are overweight or obese with a confirmed fatty liver, but who do not have cirrhosis or other liver conditions.

Beijing, Beijing Municipality
NCT06798948Recruiting· Phase 2
Can a mix of herbs improve mild fatty liver?

This study is testing if a combination of four herbs (artichoke, milk thistle, turmeric, and licorice root) can help people with non-alcoholic mild to moderate fatty liver disease (also called metabolic-associated fatty liver disease). It's a randomized trial, meaning participants are assigned to either the herbal mix or a comparison group. This may offer a natural option to support liver health.

Hangzhou, Select...
NCT07692438Recruiting
Can Taiwan green propolis help with fatty liver and body fat?

This trial tests whether a natural supplement called Taiwan green propolis can improve blood fats and reduce body fat in people with fatty liver disease (MASLD). If you have fatty liver plus at least one related health issue like high cholesterol, diabetes, or high blood pressure, you may be eligible.

Dalin

Hear when a new Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.